Rotavirus infection following post-transplantation cyclophosphamide based haploidentical hematopoietic cell transplantation in children is associated with hemophagocytic syndrome and high mortality.
Sarita Rani JaiswalPrakash BhakuniAditi ChakrabartiSuparno ChakrabartiPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
We evaluated the incidences and consequences of rotavirus induced diarrhea in a cohort of 115 patients undergoing T-cell replete haploidentical transplantation. Four out of 115 patients developed rotavirus-induced diarrhea between 47 and 147 days. The incidence of rotavirus infection was 9.7% in children compared to none in adults (P = .01). This was 25.3% in those with GVHD compared to 1.2% in those without GVHD (P = .001). Rotavirus infection was followed by post-transplantation hemophagocytic syndrome (PTHPS) at a median of 4 days (range, 3-10 days) in all four patients. Three patients succumbed to the complications related to PTHPS. Only one patient, who is long-term survivor, was able to eliminate this virus after 2 weeks. Children undergoing T-replete haploidentical hematopoietic cell transplantation who develop GVHD are at a higher risk of community-acquired rotavirus infection which was strongly associated with PTHPS with poor outcome.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- patients undergoing
- young adults
- bone marrow
- prognostic factors
- healthcare
- risk factors
- case report
- stem cells
- high glucose
- low dose
- type diabetes
- oxidative stress
- allogeneic hematopoietic stem cell transplantation
- high dose
- patient reported outcomes
- cardiovascular events
- endothelial cells
- drug induced
- gestational age
- irritable bowel syndrome